Keywords: fda, panel, backs, otc, use, schering-plough, claritin

FDA panel backs OTC use of Schering-Plough's Claritin for hives

Article | 29 April 2002

Print This

Schering-Plough moved a step closer to the fruition of plans for itsantihistamine drug Claritin (loratadine), after a US Food and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in